Crossmark

Effects of treatment refractoriness and brain-derived neurotrophic factor Val66Met polymorphism on antidepressant response to low-dose ketamine infusion

Crossref DOI link: https://doi.org/10.1007/s00406-021-01264-w

Published Online: 2021-05-07

Published Print: 2021-10

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Chen, Mu-Hong

Lin, Wei-Chen

Tsai, Shih-Jen

Li, Cheng-Ta

Cheng, Chih-Ming

Wu, Hui-Ju

Bai, Ya-Mei

Hong, Chen-Jee

Tu, Pei-Chi

Su, Tung-Ping
License Information

Text and Data Mining valid from 2021-05-07

Version of Record valid from 2021-05-07
More Information

Article History

Received: 17 September 2020

Accepted: 22 April 2021

First Online: 7 May 2021

Declarations

:

: None of the authors in this study had any conflict of interest to declare.

Document is current

Any future updates will be listed below